Acute Guillain Barré polyradiculoneuritis indicative of COVID-19 infection: a case report

Atakla, Hugues Ghislain; Noudohounsi, Mahugnon Maurel Ulrich Dénis; Sacca, Hélène; Tassiou, Nana Rahamatou; Noudohounsi, Wilfried Cadnel; Houinato, Dismand Stéphan

doi:10.11604/pamj.supp.2020.35.2.25745

Cited by 5 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The most significant complications were as follows: three patients developed hyponatremia, three patients reported depression, and two patients developed urinary retention. One patient developed heparin-induced thrombocytopenia, one patient had deep vein thrombosis and bacterial infection, one patient developed persistent urinary incontinence and transient fecal incontinence, constant neuropathic pain was seen in one patient, and one patient had a deficiency in zinc, folate, copper, and borderline B-12 [ 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 ].…”

Section: Resultsmentioning

confidence: 99%

“…Our review had some strengths. Firstly, the inclusion of 73 cases report [ 5 , 12 , 13 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 27 , 29 , 30 , 31 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , ...…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Guillain-Barré Syndrome in the COVID-19 Pandemic

Tawakul

Al-Doboke

Altayyar

et al. 2021

Neurology International

View full text Add to dashboard Cite

There have been several reported cases of severe acute respiratory syndrome (SARS-CoV-2) infection that were associated with an increased incidence of neurological manifestations, including Guillain–Barré syndrome (GBS). This review aims to present information on the reports of GBS associated with coronavirus disease 2019 (COVID-19) infection. Our review is retrospective work examining articles published from the 1 April 2020 to the 8 May 2021 in the English language. We used the diagnostic criteria and classification published by the National Institute of Neurological Disorders and Stroke and Brighton Collaboration. GBS is usually a postinfectious syndrome, but GBS in the COVID-19 pandemic also takes on a para-infectious profile. In the reports, the genetic factor has a role in developing GBS in some patients. In conclusion, the association between COVID-19 and GBS is not very clear. Still, one mechanism is strongly associated with COVID-19 and immune-mediated neurological complications, which is molecular mimicry between SARS-CoV-2 and human autoantigens.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Guillain-Barré Syndrome in the COVID-19 Pandemic

Tawakul

Al-Doboke

Altayyar

et al. 2021

Neurology International

View full text Add to dashboard Cite

show abstract

Brain and Central Nervous System Infections: Viruses

Almeida

2022

Encyclopedia of Infection and Immunity

View full text Add to dashboard Cite

Cerebrospinal fluid from COVID-19 patients with olfactory/gustatory dysfunction: A review

Lewis

Frontera

Placantonakis

et al. 2021

Clinical Neurology and Neurosurgery

View full text Add to dashboard Cite

Objective We reviewed the literature on cerebrospinal fluid (CSF) testing in patients with altered olfactory/gustatory function due to COVID-19 for evidence of viral neuroinvasion. Methods We performed a systematic review of Medline and Embase to identify publications that described at least one patient with COVID-19 who had altered olfactory/gustatory function and had CSF testing performed. The search ranged from December 1, 2019 to November 18, 2020. Results: We identified 51 publications that described 70 patients who met inclusion criteria. Of 51 patients who had CSF SARS-CoV-2 PCR testing, 3 (6%) patients had positive results and 1 (2%) patient had indeterminate results. Cycle threshold (Ct; the number of amplification cycles required for the target gene to exceed the threshold, which is inversely related to viral load) was not provided for the patients with a positive PCR. The patient with indeterminate results had a Ct of 37 initially, then no evidence of SARS-CoV-2 RNA on repeat testing. Of 6 patients who had CSF SARS-CoV-2 antibody testing, 3 (50%) were positive. Testing to distinguish intrathecal antibody synthesis from transudation of antibodies to the CSF via breakdown of the blood-brain barrier was performed in 1/3 (33%) patients; this demonstrated antibody transmission to the CSF via transudation. Conclusion Detection of SARS-CoV-2 in CSF via PCR or evaluation for intrathecal antibody synthesis appears to be rare in patients with altered olfactory/gustatory function. While pathology studies are needed, our review suggests it is unlikely that these symptoms are related to viral neuroinvasion.

show abstract

Acute Guillain Barré polyradiculoneuritis indicative of COVID-19 infection: a case report

Cited by 5 publications

References 0 publications

Guillain-Barré Syndrome in the COVID-19 Pandemic

Guillain-Barré Syndrome in the COVID-19 Pandemic

Brain and Central Nervous System Infections: Viruses

Cerebrospinal fluid from COVID-19 patients with olfactory/gustatory dysfunction: A review

Contact Info

Product

Resources

About